These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 10623824

  • 1. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS.
    J Immunol; 2000 Jan 15; 164(2):786-94. PubMed ID: 10623824
    [Abstract] [Full Text] [Related]

  • 2. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
    Sekine H, Reilly CM, Molano ID, Garnier G, Circolo A, Ruiz P, Holers VM, Boackle SA, Gilkeson GS.
    J Immunol; 2001 May 15; 166(10):6444-51. PubMed ID: 11342671
    [Abstract] [Full Text] [Related]

  • 3. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS.
    Kidney Int; 2004 Jan 15; 65(1):129-38. PubMed ID: 14675043
    [Abstract] [Full Text] [Related]

  • 4. Absence of functional alternative complement pathway alleviates lupus cerebritis.
    Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ.
    Eur J Immunol; 2007 Jun 15; 37(6):1691-701. PubMed ID: 17523212
    [Abstract] [Full Text] [Related]

  • 5. Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/lpr Mice.
    Machida T, Sakamoto N, Ishida Y, Takahashi M, Fujita T, Sekine H.
    Front Immunol; 2018 Jun 15; 9():1191. PubMed ID: 29892304
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice.
    Grossman TR, Hettrick LA, Johnson RB, Hung G, Peralta R, Watt A, Henry SP, Adamson P, Monia BP, McCaleb ML.
    Immunobiology; 2016 Jun 15; 221(6):701-8. PubMed ID: 26307001
    [Abstract] [Full Text] [Related]

  • 7. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb 15; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

  • 8. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.
    Sekine H, Kinser TT, Qiao F, Martinez E, Paulling E, Ruiz P, Gilkeson GS, Tomlinson S.
    Arthritis Rheum; 2011 Apr 15; 63(4):1076-85. PubMed ID: 21452327
    [Abstract] [Full Text] [Related]

  • 9. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus.
    Sekine H, Graham KL, Zhao S, Elliott MK, Ruiz P, Utz PJ, Gilkeson GS.
    J Immunol; 2006 Nov 15; 177(10):7423-34. PubMed ID: 17082662
    [Abstract] [Full Text] [Related]

  • 10. Complement Properdin Determines Disease Activity in MRL/lpr Mice.
    Alaridhee H, Alharbi A, Saeed Z, Thomas RC, Stover CM.
    Medicina (Kaunas); 2020 Aug 27; 56(9):. PubMed ID: 32867176
    [Abstract] [Full Text] [Related]

  • 11. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K, Deng Y, Shang S, Tang L, Li Q, Bai X, Chen X.
    Biomed Pharmacother; 2022 Sep 27; 153():113433. PubMed ID: 36076550
    [Abstract] [Full Text] [Related]

  • 12. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.
    Robson MG, Cook HT, Botto M, Taylor PR, Busso N, Salvi R, Pusey CD, Walport MJ, Davies KA.
    J Immunol; 2001 Jun 01; 166(11):6820-8. PubMed ID: 11359841
    [Abstract] [Full Text] [Related]

  • 13. IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr mice.
    Greenspan NS, Lu MA, Shipley JW, Ding X, Li Q, Sultana D, Kollaros M, Schreiber JR, Fu P, Putterman C, Emancipator SN.
    Biol Direct; 2012 Jan 16; 7():3. PubMed ID: 22248284
    [Abstract] [Full Text] [Related]

  • 14. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B, Kashgarian MJ, Sharpe AH, Mamula MJ.
    J Immunol; 2000 Sep 15; 165(6):3436-43. PubMed ID: 10975864
    [Abstract] [Full Text] [Related]

  • 15. Complement factor H deficiency accelerates development of lupus nephritis.
    Bao L, Haas M, Quigg RJ.
    J Am Soc Nephrol; 2011 Feb 15; 22(2):285-95. PubMed ID: 21148254
    [Abstract] [Full Text] [Related]

  • 16. Nephritogenicity of the lprcg gene on the MRL background.
    Kimura M, Ogata Y, Shimada K, Wakabayashi T, Onoda H, Katagiri T, Matsuzawa A.
    Immunology; 1992 Jul 15; 76(3):498-504. PubMed ID: 1526655
    [Abstract] [Full Text] [Related]

  • 17. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice.
    Gyotoku Y, Abdelmoula M, Spertini F, Izui S, Lambert PH.
    J Immunol; 1987 Jun 01; 138(11):3785-92. PubMed ID: 3495570
    [Abstract] [Full Text] [Related]

  • 18. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
    Atkinson C, Qiao F, Song H, Gilkeson GS, Tomlinson S.
    J Immunol; 2008 Jan 15; 180(2):1231-8. PubMed ID: 18178863
    [Abstract] [Full Text] [Related]

  • 19. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C, Zhao ML, Scearce RM, Diaz M.
    Arthritis Rheum; 2011 Apr 15; 63(4):1086-96. PubMed ID: 21225690
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R, Shibata T, De Kossodo S, Izui S.
    Eur J Immunol; 1989 Nov 15; 19(11):2131-7. PubMed ID: 2599002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.